OrbusNeich Medical Group Holdings Limited

As of December 31, 2025, OrbusNeich Medical Group Holdings Limited carries a market capitalization of 273.32M, placing it among publicly traded companies globally. Its enterprise value stands at 91.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

OrbusNeich Medical Group Holdings Limited's next confirmed earnings release is scheduled for March 11, 2027.

As of December 31, 2025, OrbusNeich Medical Group Holdings Limited has 823.25M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, OrbusNeich Medical Group Holdings Limited maintains a current ratio of 10.54, meaning it holds 10.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on September 17, 2026, OrbusNeich Medical Group Holdings Limited's stock has declined approximately 16.98% over the past 52 weeks. The 50-day moving average sits at 0.36, while the 200-day moving average is 0.36.

As of December 31, 2025, OrbusNeich Medical Group Holdings Limited holds 186.14M in cash and equivalents against 3.33M in total debt, resulting in a net debt position of -186.14M. Total book value stands at 351.55M, with working capital of 270.13M providing operational flexibility.